Table 3 Patient’s chance of CPP referral initiated by the GP, expressed as adjusted prevalence ratios (PRs) by cancer site and total (N=3,672)
| Â | Colorectal | Lung | Malignant melanoma | Breast | Prostate | Other | Total |
|---|---|---|---|---|---|---|---|
| Â | PRR (95% CI) | PRR (95% CI) | PRR (95% CI) | PRR (95% CI) | PRR (95% CI) | PRR (95% CI) | PRR (95% CI) |
Gender | Â | Â | Â | Â | Â | Â | Â |
Male | 1.08(0.88-1.32) | 1.02(0.81-1.27) | 1.02(0.72-1.44) | n/a | 1.00 | 1.22 (1.03-1.44) | 1.12 (1.00-1.24) |
Female | 1.00(ref) | 1.00(ref) | 1.00(ref) | 1.00 | n/a | 1.00(ref) | 1.00(ref) |
Age groups (years): | Â | Â | Â | Â | Â | Â | Â |
18-44 | 1.67(0.87-3.18) | 0.64(0.09-4.32) | 1.16(0.60-2.21) | 0.86(0.69-1.09) | - | 0.98(0.71-1.34) | 1.04(0.88-1.24) |
45-54 | 1.02(0.63-1.66) | 0.72(0.43-1.22) | 1.09(0.54-2.19) | 0.78 (0.64-0.96) | 1.70(0.98-2.93) | 1.04(0.78-1.39) | 0.97(0.84-1.12) |
55-64 | 1.49(1.11-2.00) | 0.94(0.68-1.29) | 1.69(0.88-3.26) | 0.80 (0.65-1.00) | 1.33(0.96-1.83) | 1.05(0.82-1.36) | 1.11(0.98-1.26) |
65-74 | 1.18(0.91-1.54) | 1.09(0.83-1.42) | 1.39(0.72-2.68) | 0.88(0.72-1.07) | 1.38 (1.04-1.84) | 0.92(0.72-1.17) | 1.06(0.95-1.18) |
> = 75 | 1.00(ref) | 1.00(ref) | 1.00(ref) | 1.00(ref) | 1.00(ref) | 1.00(ref) | 1(ref) |
GP’s symptom interpretation |  |  |  |  |  |  |  |
Alarm | 1.00(ref) | 1.00(ref) | 1.00(ref) | 1.00(ref) | 1.00(ref) | 1.00(ref) | 1.00(ref) |
Serious | 0.27(0.17-0.41) | 0.64 (0.49-0.85) | n/a | 0.23(0.09-0.56) | 0.71(0.47-1.06) | 0.34 (0.26-0.45) | 0.40 (0.34-0.48) |
Vague | 0.40(0.30-0.54) | 0.83(0.65-1.05) | 0.76(0.52-1.13) | 0.27 (0.17-0.43) | 0.72 (0.58-0.90) | 0.44 (0.35-0.55) | 0.53 (0.48-0.60) |